These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9860409)

  • 1. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective randomized trial of intravenous ciprofloxacin for prevention of bacterial infection in cirrhotic patients with esophageal variceal bleeding].
    Hong SN; Kim BJ; Lee SY; Lee CY; Ryu MK; Choi MS; Lee JH; Rhee PL; Koh KC; Kim JJ; Paik SW; Rhee JC; Choi KW
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):288-96. PubMed ID: 12499786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.
    Pauwels A; Mostefa-Kara N; Debenes B; Degoutte E; Lévy VG
    Hepatology; 1996 Oct; 24(4):802-6. PubMed ID: 8855179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
    Hsieh WJ; Lin HC; Hwang SJ; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1998 Jun; 93(6):962-6. PubMed ID: 9647029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
    Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
    Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
    Bernard B; Grangé JD; Khac EN; Amiot X; Opolon P; Poynard T
    Hepatology; 1999 Jun; 29(6):1655-61. PubMed ID: 10347104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perioperative antimicrobial prophylaxis for colonic surgery: Present status in Germany. A prospective multicenter study with and without Metronidazole].
    Mittelkötter U; Rau HG; Thiede A; Schildberg FW; Kullmann KH
    Zentralbl Chir; 2001 Oct; 126(10):799-804. PubMed ID: 11727192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S; Sharma A; Bhatt G
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract]   [Full Text] [Related]  

  • 17. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
    Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
    Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V; Deibert P; Ochs A; Rossle M; Gerbes AL
    Hepatogastroenterology; 1999; 46(26):1126-30. PubMed ID: 10370679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.